Skip to main content

Table 3 Patient characteristics at the time of stoma creation

From: Clinicopathological and prognostic evaluations of anorectal cancer after fecal diversion for patients with Crohn’s disease

 

Overall n = 204

Diverted ARC

Non-diverted ARC

p value

Sex (male/female)

140/64

5/6

135/58

0.10

Onset age of CD (years)

19 (1–63)

18 (3–31)

19 (1–63)

0.13

Extent of CD (ileocolitis/colitis)

195/9

9/2

186/7

0.43

Age at stoma creation (years)

32 (10–69)

35 (24–47)

32 (10–69)

0.85

Duration from diagnosis to stoma (months)

142 (2–462)

227 (36–350)

138 (2–462)

0.07

Indication of stoma (anorectal lesion/refractory colitis)

158/46

10/1

148/45

0.29

Site of stoma (ileo(jejuno)stomy/colostomy)

112/92

4/7

108/85

0.21

Type of stoma (loop/end)

102/102

7/4

95/98

0.35

Continuous symptom after stoma creation

57 (27.9)

1 (9.0)

56 (29.5)

0.18

Biologic administration

17 (8.3)

2 (18.1)

15 (8.8)

0.24

Surveillance biopsy for diverted intestinal tract

23 (11.2)

1 (9.0)

21 (10.8)

0.88

CD duration (months)

138 (34–417)

85 (42–417)

143(34–378)

0.20

Duration of fecal diversion (months)

98 (24–382)

46 (24–382)

104 (24–346)

0.21

  1. Data are numbers with percentages in parentheses, unless otherwise indicated. Continuous variables are indicated as median (range)
  2. CD Crohn's disease, ARC anorectal cancer